Search Results for ''

published presentations and documents on DocSlides.

TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Switch to LPV/ r  + 3TC OLE
Switch to LPV/ r + 3TC OLE
by susan2
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Gilead Sciences, Inc., Foster City, CA, USA
Gilead Sciences, Inc., Foster City, CA, USA
by phoebe-click
Gilead Sciences, Inc., Foster City, CA, USA FTC/T...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
x0000x00001  xMCIxD 0 xMCIxD 0 Dissenting Statement of Commissioner
x0000x00001 xMCIxD 0 xMCIxD 0 Dissenting Statement of Commissioner
by margaret
In the Matter of Nomi Technologies Inc FTC File No...
Joel E. Gallant, MD, MPH
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Switch to LPV/
Switch to LPV/
by lindy-dunigan
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
CROI 2015: What’s New in Hepatitis?
CROI 2015: What’s New in Hepatitis?
by myesha-ticknor
Nina Kim, MD . Associate Professor of Medicine. D...
Susan P. Buchbinder, MD Director, Bridge HIV
Susan P. Buchbinder, MD Director, Bridge HIV
by harmony
San . Francisco Department . of Public Health. Cli...
Class 16 Antitrust Winter 2019
Class 16 Antitrust Winter 2019
by pamella-moone
Class 16 Antitrust Winter 2019 Modern Horizontal ...
MassHealth Demonstration
MassHealth Demonstration
by briana-ranney
to Integrate Care for Dual Eligibles. One Care: M...
Second-Generation  HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
by sherrill-nordquist
± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...
APRNS:  At the table or on the Menu…..
APRNS: At the table or on the Menu…..
by cheryl-pisano
take your pick. Feb 2017. Dr. Stephanie Burgess, ...
Understanding  Cybersecurity Risks: Issues & Trends
Understanding Cybersecurity Risks: Issues & Trends
by sherrill-nordquist
. Association . of Corporate Counsel. © 2015. ...
Overview of HIV Epidemiology and Prevention Sciences for ke
Overview of HIV Epidemiology and Prevention Sciences for ke
by alida-meadow
Stefan Baral, MD MPH FRCPC. Center for Public Hea...
CROI 2015: HIV Prevention Updates
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...